Amgen (NasdaqGS:AMGN) recently announced a significant $900 million expansion in its Ohio manufacturing facility, aiming to ...

It's always a good time to buy solid dividend stocks, but considering the challenging economic environment, now might be a ...

US biotech giant Amgen (Nasdaq: AMGN) is the latest to build up its US base, as on Friday the company announced a $900 million expansion of its Ohio manufacturing facility, bringing the total number ...

A new drug combination shows promise for colon cancer patients whose disease no longer responds to standard chemotherapy ...

It's the first time in at least a decade that Target has donated to an inaugural committee, according to a CNBC report, which ...

Dana Cimilluca is former Wall Street bureau chief at The Wall Street Journal, where he managed a group of reporters and editors covering banks, hedge funds, private-equity firms, M&A and IPOs. He ...

A 25% tariff proposed on pharmaceutical imports could significantly impact U.S. drug prices, raising overall costs by nearly ...

The final day of the NFL Draft has arrived as the class of Buckeyes look to set a record.

Palestinian President Mahmoud Abbas on Saturday named a veteran aide and confidant as his new vice president. It’s a major ...

Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...